1. Combined onabotulinumtoxinA/atogepant treatment blocks activation/sensitization of high-threshold and wide-dynamic range neurons. (January 2021) Authors: Melo-Carrillo, Agustin; Strassman, Andrew M; Schain, Aaron J; Adams, Aubrey Manack; Brin, Mitchell F; Burstein, Rami Journal: Cephalalgia Issue: Volume 41:Number 1(2021) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Exploring the effects of extracranial injections of botulinum toxin type A on prolonged intracranial meningeal nociceptors responses to cortical spreading depression in female rats. (October 2019) Authors: Melo-Carrillo, Agustin; Strassman, Andrew M; Schain, Aaron J; Noseda, Rodrigo; Ashina, Sait; Adams, Aubrey; Brin, Mitchell F; Burstein, Rami Journal: Cephalalgia Issue: Volume 39:Number 11(2019) Page Start: 1358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier. (March 2020) Authors: Noseda, Rodrigo; Schain, Aaron J; Melo-Carrillo, Agustin; Tien, Jason; Stratton, Jennifer; Mai, Fanny; Strassman, Andrew M; Burstein, Rami Journal: Cephalalgia Issue: Volume 40:Number 3(2020) Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗